Thiel Capital
VC Fund
Los Angeles, United States
Thiel Capital is an investment firm founded by Peter Thiel. Located in Los Angeles, Thiel Capital provides strategic and operational support for Peter’s many investment initiatives and entrepreneurial endeavors. Related organizations include Founders Fund, Mithril, Valar Ventures, and The Thiel Foundation.
- Total investments:
- 52
- Last investment:
- Lead investor:
- 29%
- Fund size:
- $400M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Thiel Capital invests in
Stages Thiel Capital invests in
Countries Thiel Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 10 (19%)
- Biotechnology 9 (17%)
- Software 6 (12%)
- Therapeutics 5 (10%)
- Medical 4 (8%)
Stage
- Seed 15 (29%)
- Series A 10 (19%)
- Venture - Series Unknown 5 (10%)
- Series B 4 (8%)
- Pre-Seed 3 (6%)
Country
- United States 22 (42%)
- Germany 4 (8%)
- Singapore 2 (4%)
- China 1 (2%)
- Israel 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Eric Weinstein
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Jack R. Selby
Managing Director
|
Managing Director | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Neros Technologies is a defense technology company specializing in the development and manufacturing of advanced unmanned aerial systems (UAS). The Neros Archer, the company's flagship product, is a high-performance, long-range First-Person View (FPV) drone certified by BlueUAS. Designed for large-scale deployment, it is optimized forlong-range missions with resistance to electronic warfare and can carry a 2 kg (approximately 4.5 lbs) payload over a distance of 20 kilometers. | $250M / Series C / Aug 11, 2026 | ||
| Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Lexington, Massachusetts. | $40M / Series E / Apr 15, 2026 | ||
| STARK is a developer of integrated defense and security systems intended for tactical and strategic protection in military and law enforcement missions. | $62M / Venture - Series Unknown / Aug 21, 2025 | ||
Pilgrim
|
Pioneering a biologically enhanced future for humanity. | $4.3M / Seed / Aug 06, 2025 | |
|
Pilgrim
|
Pioneering a biologically enhanced future for humanity. | $3.3M / Pre-Seed / Mar 17, 2025 | |
|
Pilgrim
|
Pioneering a biologically enhanced future for humanity. | Seed / Mar 17, 2025 | |
| Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools. | $17M / Seed / Feb 27, 2025 | ||
| EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will targetimproving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP). | Venture - Series Unknown / Sep 03, 2024 | ||
| Fantasy Chess is a platform that allows users to pick teams of real-world chess players, track their performance in tournaments, and receive points based on their achievement. | $3M / Pre-Seed / Jun 25, 2024 | ||
| Rhea is a reproductive health services firm focused on improving the modern family's fertility journey. | Venture - Series Unknown / May 30, 2024 | ||
| See all 52 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Thiel Capital invest in?
Thiel Capital invests primarily in Health Care, Biotechnology and Software startups, most often at Seed and Series A stage. Most of the 52 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Thiel Capital?
Public channels for Thiel Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Thiel Capital?
The team at Thiel Capital includes Eric Weinstein (Managing Director) and Jack R. Selby (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
